Selected Publications
Ying WANG, Alicia Huaze Li, Ruqayyah sanders-Braggs, Yan Zhou, Mimi Chen, Tien Bui, Hongfa Zhu, Nasheed Hossain, Jonathan Soboloff, John Elrod, Elizabeth O. Hexner, Yi Zhang: Enforced Expression of Mitochondrial Calcium Uniporter in Donor T Cells Abolishes Gvhd Progression
Blood : 2024.
Benjamin F. Frost, Olga Shestova, Sara Sleiman, Brandon Simone, Feng Shen, Miroslaw Kozlowski, Michelle Wang, J. Joseph Melenhorst, Noelle Frey, Elizabeth O. Hexner, Megan M. Davis, Joseph A. Fraietta, Avery Gaymon, Rong Xu, Chia Sharpe, John C. Byrd, Mark O'Hara, Adam D. Cohen, Stephen J. Schuster, Donald L. Seigel, Carl H. June, David L. Porter, Saar Gill: BTK Inhibition Prevents the Induction of Myeloid-Derived Suppressor Cells in Malignancy and Improves CART Function Blood : 2024.
Naseema Gangat, James M. Foran, Anna B. Halpern, Raajit Rampal, Prithviraj Bose, Elizabeth O. Hexner, Moshe Talpaz, Laura C. Michaelis, Prioty Islam, Ronan T. Swords, Sima Bhatt, Akshay Buch, Olivia Pelletier, Will Savage, Ayalew Tefferi: A Phase 1b Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia Blood : 2024.
Benjamin F. Frost, Noelle Frey, Elizabeth O. Hexner, Stephen J. Schuster, Sunita D. Nasta, Alison W Loren, Jakub Svoboda, Daniel J. Landsburg, Bruce Levine, Joseph A. Fraietta, J. Joseph Melenhorst, Elizabeth Veloso, Wei-Ting Hwang, Carl H. June, David L. Porter, Saar Gill: Curing CLL: Long-Term Outcomes of Chronic Lymphocytic Leukemia Patients with at Least One Year of Response to CART-19 Therapy Blood : 2024.
Yu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, Hideki Nakasone, Francis A. Ayuk, Hannah Choe, Noriko Doki, Tetsuya Eto, Aaron Etra, Elizabeth O. Hexner, Nobuhiro Hiramoto, William J. Hogan, Ernst Holler, Keisuke Kataoka, Masatsugu Tanaka, Takashi Tanaka, Naoyuki Uchida, Ingrid Vasova, Fumihiko Ishimaru, Takahiro Fukuda, Yi-Bin Chen, Junya Kanda, Ryotaro Nakamura, Yoshiko Atsuta, James L.M. Ferrara, Yoshinobu Kanda, John Levine, Takanori Teshima: Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC Blood : 2024.
Nikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, Ingrid Vasova, Francis A. Ayuk, Hannah Choe, William J. Hogan, Zachariah Defilipp, Muna Qayed, Aaron Etra, Karamjeet S Sandhu, Sabrina Kraus, Timothy S. Olson, Elizabeth O. Hexner, Paibel Aguayo-Hiraldo, Ran Reshef, Evelyn Ullrich, Tal Schechter-Finkelstein, Carrie L. Kitko, Chantiya Chanswangphuwana, Pietro Merli, Yu Akahoshi, Janna Baez, Gilbert Eng, Rahnuma Beheshti, Steven Kowalyk, George Morales, Ioannis Evangelos Louloudis, Rachel Young, Ernst Holler, Ryotaro Nakamura, James L.M. Ferrara, John Levine: Serial Clinical and Biomarker Monitoring during Treatment Can Stratify Patients with Low Risk Gvhd Blood : 2024.
Grady CB, Li Y, Maude SL, Hexner EO, Frey NV, Porter DL, Hwang WT.: Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A Review Transplant Cell Ther : 2024.
Ghilardi, G., Fraietta, J. A., Gerson, J. N., Van Deerlin, V. M., Morrissette, J. J. D., Caponetti, G. C., Paruzzo, L., Harris, J. C., Chong, E. A., Susanibar Adaniya, S. P., Svoboda, J., Nasta, S. D., Ugwuanyi, O. H., Landsburg, D. J., Fardella, E., Waxman, A. J., Chong, E. R., Patel, V., Pajarillo, R., Kulikovskaya, I., Lieberman, D. B., Cohen, A. D., Levine, B. L., Stadtmauer, E. A., Frey, N. V., Vogl, D. T., Hexner, E. O., Barta, S. K., Porter, D. L., Garfall, A. L., Schuster, S. J., June, C. H., Ruella, M.: T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy Nat Med 30 (4): 984-989,2024.
Hexner, E. O.: The splendor and the tyranny of JAK inhibition Haematologica 109 (2): 369-370,2024.
Gotlib, J., Gerds, A. T., Abdelmessieh, P., Ali, H., Castells, M., Dunbar, A., Fein Revell, R., George, T. I., Green, S., Gundabolu, K., Hexner, E., Jain, T., Jamieson, C., Kaesberg, P. R., Kuykendall, A. T., Madanat, Y., Manchanda, N., Masarova, L., May, J., McMahon, B., Mohan, S. R., Nadiminti, K. V., Oh, S., Palmer, J., Patel, A., Patel, A. A., Podoltsev, N., Rein, L., Salit, R., Talpaz, M., Wadleigh, M., Wall, S., Bergman, M. A., Hochstetler, C.: NCCN Guidelines(R) Insights: Systemic Mastocytosis, Version 3.2024 J Natl Compr Canc Netw 22 (2D): 2024.
Academic Contact Information
Division of Hematology Oncology
Perelman Center for Advanced Medicine
12th Floor, South Pavilion
Office #12-151
3400 Civic Center Boulevard
Philadelphia,
PA
19104
Phone: 215-614-1847
Patient appointments: 800-789-7366